UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of
the Securities Exchange Act of 1934
Date of Report: April 14, 2004
(Date of earliest event reported)
VASOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-18105 11-2871434
-------- ------- ----------
(State or other jurisdiction of Commission (I.R.S. Employer
incorporation or organization) File Number) Identification Number)
180 Linden Avenue, Westbury, New York 11590
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code (516) 997-4600
(Former name or former address, if changed since last report.)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
--------
99 Press release dated April 14, 2004 issued by Vasomedical, Inc.
("Registrant").
Item 12. Results of Operations and Financial Condition
On April 14, 2004, the Registrant issued a press release announcing the
Registrant's financial results for the third quarter ended February 29, 2004. A
copy of the Registrant's press release is attached as Exhibit 99.
The information in this Form 8-K is being furnished under Item 12 and shall
not be deemed to be "filed" for the purposes of Section 18 of the Securities and
Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the
liabilities of such section, nor shall such information be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing.
Signatures
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
VASOMEDICAL, INC.
By:/s/ Thomas W. Fry
-----------------------------------
Thomas W. Fry
Chief Financial Officer
(Principal Financial and Accounting
Officer)
Dated: April 15, 2004